MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1590/2175-8239-jbn-2023-0036en

Медицинская библиотека · Jornal brasileiro de nefrologia · 2024

Progression of valve heart disease in a cohort of patients undergoing renal replacement therapy.

Tompson Maria Eduarda Cavalcanti, Pimentel José Arthur Viana de Oliveira, Silva Manuella de Amorim, Santos-Veloso Marcelo Antônio Oliveira, Lordsleem Andrea Bezerra de Melo da Silveira, Lima Sandro Gonçalves de

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

Cardiovascular disease is an important cause of death among patients with chronic kidney disease (CKD). Valve calcification is a predictor of cardiovascular mortality and coronary artery disease.

OBJECTIVE

To assess heart valve disease frequency, associated factors, and progression in CKD patients.

METHODS

We conducted a retrospective study on 291 CKD patients at Hospital das Clínicas de Pernambuco. Inclusion criteria were age ≥ 18 with CKD and valve disease, while those on conservative management or with missing data were excluded. Clinical and laboratory variables were compared, and patients were categorized by dialysis duration (<5 years; 5-10 years; >10 years). Statistical tests, including chi-square, Fisher's exact, ANOVA, and Kruskal-Wallis, were employed as needed. Simple and multivariate binary regression models were used to analyze valve disease associations with dialysis duration. Significance was defined as p < 0.05.

RESULTS

Mitral valve disease was present in 82.5% (240) of patients, followed by aortic valve disease (65.6%; 86). Over time, 106 (36.4%) patients developed valve disease. No significant association was found between aortic, pulmonary, mitral, or tricuspid valve disease and dialysis duration. Secondary hyperparathyroidism was the sole statistically significant factor for mitral valve disease in the regression model (OR 2.59 [95% CI: 1.09-6.18]; p = 0.031).

CONCLUSION

CKD patients on renal replacement therapy exhibit a high frequency of valve disease, particularly mitral and aortic valve disease. However, no link was established between dialysis duration and valve disease occurrence or progression.

Для цитирования: Tompson Maria Eduarda Cavalcanti, Pimentel José Arthur Viana de Oliveira, Silva Manuella de Amorim, Santos-Veloso Marcelo Antônio Oliveira, Lordsleem Andrea Bezerra de Melo da Silveira, Lima Sandro Gonçalves de. Progression of valve heart disease in a cohort of patients undergoing renal replacement therapy.. Jornal brasileiro de nefrologia. 2024. DOI: 10.1590/2175-8239-jbn-2023-0036en.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.